| abstract |
The present invention provides compounds of formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein all variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. The present invention also relates to pharmaceutical compositions comprising these compounds and methods of using them to treat thromboembolic and/or inflammatory disorders. |